SEC Form 4 · accession 0001437749-18-012464
CESCA THERAPEUTICS INC. · KOOL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Xu
Officer — Sr. VP, Legal Affairs · Director
Period of report
Jun 22, 2018
Accepted (ET)
Jun 26, 2018 · 7:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $0.437 | Jun 22, 2018 | A | 13,500 | A | — | Jun 22, 2028 | Common Stock | 13,500 | 13,500 | D |
Explanation of responses
- F1Option vests quarterly over a three year period.